期刊文献+

高通量测序技术在五类疾病分子诊断中的应用及质量管理策略 被引量:10

Application and quality management of high-throughput sequencing in clinical molecular diagnosis of five kinds of diseases
原文传递
导出
摘要 高通量测序技术(high-throughput sequencing)又称下一代测序(next generation sequencing,NGS)能一次并行对成千上万个基因进行测序,极大地提高了DNA测序效率并降低了成本。近年来,NGS在医学研究和临床诊断中的应用日益广泛,在无创产前筛查,肿瘤筛查、诊断和治疗,微生物病原体检测,遗传性疾病的筛查与诊断及器官移植排斥筛查等多个领域具有广泛的应用前景。NGS技术作为一项新兴技术,在相关临床应用中也存在诸多问题,其质量管理体系尚不完善,还面临许多挑战,需要医学实验室和相关部门共同努力,以促进NGS在临床诊断中规范开展。 High-throughput sequencing, also known as the high-throughput next generation sequencing(NGS), can sequence thousands of genes at one time, greatly improve the efficiency of DNA sequencing and reduce the cost. Recently, NGS has been widely used in medical research and clinical diagnosis. It has extensive applications in non-invasive prenatal screening, tumor screening, diagnosis and treatment, microbial pathogens detection, genetic diseases screening and diagnosis as well as organ transplantation rejection screening. However, as a new technology, NGS also has many issues in related clinical application. The quality management system is still imperfect and faces many challenges. Thus the joint efforts of medical laboratories and related departments are needed to promote the standardization of NGS in clinical diagnosis.
作者 鲍芸 肖艳群 王华梁 Bao Yun;Xiao Yanqun;Wang Hualiang(Department of Molecular Biology, Shanghai Center for Clinical Laboratory, Shanghai 200126, China)
出处 《中华临床实验室管理电子杂志》 2018年第2期69-73,共5页 Chinese Journal of Clinical Laboratory Management(Electronic Edition)
基金 上海市第四轮公共卫生三年行动计划-卫生检验学项目(15GWZK0301)
关键词 高通量测序 分子诊断 质量管理 Next generation sequencing technology Molecular diagnosis Quality management
  • 相关文献

参考文献2

二级参考文献27

  • 1Faycal G. Bianchi DW. Noninvasive prenatal testing cre-ates an opportunity for antenatal treatment of Down syn-drome[J]. Prenat Dia,2013 ,33(6) : 614-618.
  • 2Grati FR,Ferreira JC,Bajaj K. Noninvasive prenatal screeningfor fetal trisomies 21,18, 13 and the common sex chromo-some aneuploidies from maternal blood using massively paral-lel genomic sequencing of DNA[J]. Am J Obst Gynecol,2014,211(96) :711-712.
  • 3de Jong A,de Wert GM. Prenatal screening: an ethical a-genda for the near future[J]. Bioethics, 2015,29 (1): 46-55.
  • 4Dar P,Curnow KJ? Benn P, et al. Clinical experience andfollow-up with large scale single-nucleotide polymor-phism-basednoninvasive prenatal aneuploidy testing [J].Am J Obstet Gynecol,2014,211 (5) :527.
  • 5Sago H,Sekizawa Z. Japan NIPT consortium. Nationwidedemonstration project of next-generation sequencing ofcell-free DNA in maternal plasma in Japan:one-year expe-rience[J]. Prenat Dia,2015 ,35(4) : 331-336.
  • 6Canick JA. DNA sequencing of maternal plasma to identi-fy Down syndrome and other trisomies in multiple gesta-tions[J]. Prenatal Dia,2012,32(8) :730-734.
  • 7Jiang F,Ren J, Chen F, et al. Noninvasive Fetal Trisomy(NIFTY) test: an advanced noninvasive prenatal diagno-sis methodology for fetal autosomal and sex chromosomalaneuploidies[J]. BMC Med Geno,2012 ,5(1) :1.
  • 8Papageorgiou EA, Karagrigoriou A,Tsaliki E,et al. Fetal-specific DNA methylation ratio permits noninvasivepre-natal diagnosis of trisomy 21 [J]. Nat Med, 2011,17(4):510-513.
  • 9Yao H,Jiang F,Hu H,et al. Detection of fetal sex chro-mosome aneuploidy by massively parallel sequencing ofmaternal plasma DNA:initial experience in a Chinese hos-pital[J]. Ultrasound Obstet Gynecol,2014,44(1) :17-24.
  • 10Sehnert AJ. Optimal detection of fetal chromosomal ab- normalities by massively parallel DNA sequencing of cell- free fetal DNA from maternal blood I-J]. Clin Chem, 2011,57(7) ..1042-1049.

共引文献28

同被引文献80

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部